Testosterone – the Active Pharmaceutical Ingredient (API)
| Item | Details |
|------|---------|
| Common Name | Testosterone (often abbreviated “T”) |
| IUPAC | 17β‑hydroxyandrost‑4‑en‑3‑one |
| Molecular Formula | C₁₉H₂₈O₂ |
| Molar Mass | 288.43 g mol⁻¹ |
| CAS Registry Number | 58‑33‑9 |
| Appearance | White–yellow crystalline powder |
| Solubility | Soluble in ethanol, chloroform, acetone; sparingly soluble in water |
---
1. What “API” Means
- API = Active Pharmaceutical Ingredient – the biologically active component responsible for a drug’s therapeutic effect.
- For testosterone‑based medicines, the API is the pure hormone; it is then formulated with excipients to produce a product (gel, injection, patch, etc.).
2. Clinical Uses
| Form | Typical Indication | Common Brand (U.S.) | Typical Dose |
|------|--------------------|---------------------|--------------|
| Transdermal gel | Androgen deficiency in men | AndroGel®, Testim® | 1 g applied twice daily (≈150 mg/day) |
| Intramuscular injection (oil) | Androgen deficiency, delayed puberty | Depo‑Testosterone® | 50–100 mg every 2–3 weeks |
| Pellet | Long‑acting therapy | Testopel® | 30 mg inserted every 3–4 months |
| Oral (prodrug) | (e.g., testosterone undecanoate) | – | – |
| Sublingual, nasal, vaginal | Research, specific protocols | – | – |
Note: The dosage above is approximate; actual prescribing depends on patient weight, baseline testosterone, comorbidities, and physician judgment.
3. Pharmacokinetics (Typical for IM injection)
- Absorption: Gradual release from oil depot; peak serum levels 4–10 days post‑injection.
- Distribution: Binds mainly to sex‑binding globulin (≈90 %) and albumin.
- Metabolism: Primarily hepatic via reduction (to 5α‑dihydrotestosterone) and conjugation (glucuronidation).
- Elimination: Urinary excretion of metabolites; half‑life ~7–12 days (oil formulations).
4. Legal & Regulatory Status (U.S. / EU)
- Controlled Substance: Testosterone is Schedule IV in the U.S. (controlled, but with relatively lower abuse potential than Schedule II substances).
- Prescription‑Only: Requires a valid prescription from a licensed medical provider.
- Doping Regulations: Prohibited by the World Anti‑Doping Agency (WADA) in competitive sports unless a therapeutic use exemption (TUE) is granted.
5. Common Side Effects
- Acne, oily skin, hair loss
- Fluid retention, hypertension
- Elevated red blood cell count (polycythemia)
- Possible mood changes (irritability, aggression)
- Hepatic issues (rare, especially with oral prodrugs)
Patients on testosterone therapy are typically monitored with:
- Serum testosterone levels (target 300–800 ng/dL for adult men)
- Complete blood count (CBC)
- Liver function tests (for oral formulations)
- Prostate‑specific antigen (PSA) in men with prostate cancer risk
6. Important Safety Points
- Contraindications: Untreated prostate or breast cancer, severe heart disease, uncontrolled hypertension.
- Drug Interactions:
- Statins (may increase testosterone levels).
- CYP3A4 inhibitors (e.g., ketoconazole) can raise testosterone levels.
- Hormonal agents (e.g., oral contraceptives) may reduce efficacy.
- Storage: Store at 20–25 °C; avoid direct sunlight and high humidity.
---
Bottom Line
Testosterone is a well‑studied steroid hormone used as the API in multiple androgen‑replacement products. The specific formulation (gel, injection, pellet, etc.) dictates its pharmacokinetic profile, dosing schedule, and clinical applications. All testosterone therapies are regulated and should be used under the supervision of a qualified healthcare professional.